Nutrafol Hair Growth Ads Trigger TINA.org Complaint To Federal Agencies
Ad watchdog group Truth in Advertising, Inc. filed a complaint with the US FDA and FTC over Nutrafol hair growth supplement representations that the organization says are unapproved drug claims and/or don’t meet FTC standards for adequate substantiation, as well as alleged deceptive negative option practices.
You may also be interested in...
FTC Reminds Advertisers Large And Small: Substantiate Health Claims Or Face Civil Penalties
Agency sends flares across wide field of advertisers illuminating the need for marketers to substantiate health claims. Reminder made brighter noting penalties of up to $50,120 per violation.
Still Can’t Cancel That Gym Membership? FTC Proposes One Negative Option Rule To Rule Them All
The FTC published a notice of proposed rulemaking on 23 March to update its 1973 Negative Option Rule, which has become obsolete vis-à-vis new marketing strategies in today’s digital world. Proposed amendments would clarify, expand and consolidate negative option-related provisions currently dispersed across different FTC laws and regulations.
FTC’s Health Products Guidance: Attorneys Discuss Insistence On RCTs, Implications For Businesses
The updated and expanded guidance embodies the US Federal Trade Commission’s enforcement approach for more than a decade, identifying randomized clinical trials as the competent and reliable scientific evidence needed to back health-related claims. Attorneys from Kelley Drye & Warren, Lathrop GMP and Amin Talati Wasserman weigh in.